MYIOSHEALTH
DEAD

Serial Number

99800706

Owner

10XREVIV LTD

Attorney

Kenneth C. Booth

Filing Date

May 1, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MYIOSHEALTH Trademark

Serial Number: 99800706

MYIOSHEALTH is a trademark filed by 10XREVIV LTD on May 1, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

10XREVIV LTD (6 trademarks)

5 Churchill Place, 10th Floor
London E14 5HU , GB

Entity Type: 24

Trademark Details

Filing Date

May 1, 2026

Registration Date

Not Registered

Goods & Services

Health monitoring devices consisting of blood pressure monitors, thermometers and pedometers; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Medical devices for monitoring vital signs, blood properties and respiratory events; Body composition analyzers for medical purposes; Medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters; Medical apparatus for monitoring blood glucose levels; Wearable monitors used to measure biometric data for medical use; Medical diagnostic apparatus for testing and monitoring brain, heart and metabolic functions

Scientific research specimen collection devices in the nature of blood biomarker testing kits for the collection of blood droplet samples; Medical laboratory research instruments for collecting biological samples for laboratory analysis; Smart rings; Smart watches

Retail store services featuring personalized health and wellness products, dietary supplements, nutritional supplements, health and wellness products, medical testing kits, and personal health monitoring devices; On-line retail store services featuring personalized health and wellness products, dietary supplements, nutritional supplements, health and wellness products, medical testing kits, and personal health monitoring devices

Providing healthy lifestyle and nutrition services, namely, personal assessments, personalized routines, maintenance schedules, and counseling; Health assessment services; Consulting in the fields of health, wellness, and nutrition for personalized health optimization based on analysis of individual genetic, metabolic and biometric data; Providing information in the fields of health and wellness in the field of personalized health optimization based on analysis of individual genetic, metabolic and biometric data via a website; Medical clinic services; Health clinic services; Medical clinics; Consulting services in the fields of diagnostic medical testing and nutrition; Medical diagnostic services; Intravenous (IV) hydration therapy services; Intravenous (IV) vitamin therapy services

Dietary and nutritional supplements; Probiotic supplements; Vitamin supplements; Mineral dietary supplements; Protein dietary supplements; Dietary supplements consisting primarily of personalized nutritional supplements formulated on the basis of individual genetic and biometric data; Amino acids for nutritional purposes; Dietary supplements consisting primarily of collagen; Electrolytes for medical use; Electrolyte replacement solutions; Dietary supplements consisting primarily of adaptogens, non-toxic plants, roots or mushrooms that help the body respond to and recover from physical and mental stress; Dietary supplements consisting primarily of nicotinamide adenine dinucleotide (NAD+); Dietary supplements consisting primarily of nootropics, bacopa monnieri, ginco biloba, phosphatidylserine, caffeine, L-theanine, citicoline, Rhodiola Rosea, or Creatine; Specimen collection kits comprised primarily of swabs for medical purposes and also including reagents, collection bags, collection tubes and instructions for use in genetic, nutritional genomic analysis, and laboratory analysis

Filing History

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Oct 8, 2026 MAB1
ABANDONMENT - EXPRESS MAILED
Oct 8, 2026 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Oct 7, 2026 EXAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2026 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2026 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2026 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
May 1, 2026 MAFR
NEW APPLICATION ENTERED
May 1, 2026 NWAP